What Is The Long-term Outlook for AMC Stock?
Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…
Sell
20
CGTX Quote, Financials, Valuation and Earnings
Last price:
$0.30
Seasonality move
:
-43.38%
Day range:
$0.30 - $0.33
52-week range:
$0.22 - $2.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.52x
Volume:
2.3M
Avg. volume:
1.5M
1-year change:
-82.95%
Market cap:
$18.6M
Revenue:
--
EPS (TTM):
-$0.74
Earnings Data
Next earnings date for CGTX
Aug 08
2025
Most recent earnings per share
-$0.14
Missed by $0.03
(May 7/2025)
Consensus Estimate
-$0.12
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CGTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/08/2025 | Q2 | -- | -- | -- | -$0.11 | -- |
| 05/07/2025 | Q1 | -- | -- | -$0.14 | -$0.12 | -$0.03 |
| 03/20/2025 | Q4 | -- | -- | -$0.17 | -$0.15 | -$0.02 |
| 11/13/2024 | Q3 | -- | -- | -$0.25 | -$0.21 | -$0.04 |
| 08/08/2024 | Q2 | -- | -- | -$0.18 | -$0.23 | $0.05 |
| 05/07/2024 | Q1 | -- | -- | -$0.27 | -$0.25 | -$0.03 |
| 03/26/2024 | Q4 | -- | -- | -$0.27 | -$0.33 | $0.06 |
| 11/02/2023 | Q3 | -- | -- | -$0.22 | -$0.29 | $0.07 |
| 08/08/2023 | Q2 | -- | -- | -$0.16 | -$0.21 | $0.05 |
| 05/04/2023 | Q1 | -- | -- | -$0.21 | -$0.18 | -$0.04 |
| 03/23/2023 | Q4 | -- | -- | -$0.20 | -- | -- |
| 11/14/2022 | Q3 | -- | -- | -$0.29 | -- | -- |
| 08/09/2022 | Q2 | -- | -- | -$0.25 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.17 | -- | -- |
| 03/30/2022 | Q4 | -- | -- | -$0.34 | -- | -- |
| 11/17/2021 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.14 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.04 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.14 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.13 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.17 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.12 | -- | -- |
Cognition Therapeutics Earnings Questions
-
How Much did Cognition Therapeutics Generate in Revenue Last Quarter?
Cognition Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Cognition Therapeutics Beat Earnings Last Quarter?
Cognition Therapeutics announced earnings per share of -$0.14 which represents a miss of analyst forecast a -$0.12 per share.
-
Is Cognition Therapeutics Profitable?
Cognition Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Cognition Therapeutics EPS Next Year?
Cognition Therapeutics's earnings are forecast to decrease from -$0.86 per share to -$0.79 per share next year representing a decrease of -50.29%.
-
When is Cognition Therapeutics's Earnings Date?
Cognition Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 52x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
76
AVAV alert for Jun 26
AeroVironment [AVAV] is up 13.82% over the past day.
Buy
51
SITM alert for Jun 26
SiTime [SITM] is up 2.17% over the past day.
Buy
54
NGVC alert for Jun 26
Natural Grocers by Vitamin Cottage [NGVC] is down 3.21% over the past day.
